Back to mobile site

UBS Reiterates Buy Rating on Omega Healthcare Investors (OHI)

May 20, 2026 9:43 AM EDT Send to a Friend
UBS analyst Michael Goldsmith reiterated a Buy rating and $54.00 price target on Omega Healthcare Investors (NYSE: OHI).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login